Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Long-Term Deferred Tax (2023 - 2026)

Profound Medical has reported Long-Term Deferred Tax over the past 3 years, most recently at $66000.0 for Q4 2025.

  • For Q4 2025, Long-Term Deferred Tax fell 24.14% year-over-year to $66000.0; the TTM value through Dec 2025 reached $66000.0, down 24.14%, while the annual FY2025 figure was $66000.0, 24.14% down from the prior year.
  • Long-Term Deferred Tax for Q4 2025 was $66000.0 at Profound Medical, down from $80000.0 in the prior quarter.
  • Over five years, Long-Term Deferred Tax peaked at $101000.0 in Q2 2025 and troughed at -$76000.0 in Q4 2023.
  • A 3-year average of $24500.0 and a median of $73000.0 in 2025 define the central range for Long-Term Deferred Tax.
  • On a YoY basis, Long-Term Deferred Tax climbed as much as 234.67% in 2025 and fell as far as 24.14% in 2025.
  • Year by year, Long-Term Deferred Tax stood at -$76000.0 in 2023, then soared by 214.47% to $87000.0 in 2024, then decreased by 24.14% to $66000.0 in 2025.
  • Business Quant data shows Long-Term Deferred Tax for PROF at $66000.0 in Q4 2025, $80000.0 in Q3 2025, and $101000.0 in Q2 2025.